NAII Posts $13.5M Q4 Loss, $10.4M Impairment, and Explores Sale
NAII is trading near its 52-week low of $1.7 (0.0% above the low) on light trading volume (0.1× avg).
Summary
NAII reported a Q4 net loss of $13.5M ($2.23/share), including a $10.4M non-cash impairment on its Carlsbad facility, versus a $7.2M loss a year ago. Full-year loss widened to $20.7M ($3.43/share) from $13.6M. Sales grew 10% to $142.5M, with Q4 sales rising on royalty income, but gross margin fell to 6.3% from 7.2% due to factory underutilization. The company is consolidating manufacturing into Vista, CA, selling the Carlsbad facility, and exploring strategic alternatives including a possible sale. Cash dropped to $7.5M from $12.3M, with $7.7M drawn on a $17.7M credit line. This follows the 10-K filed today that flagged going concern risk and a debt covenant breach. The strategic review and asset sales are the key near-term catalysts, but the balance sheet remains tight.
At the time of this announcement, NAII was trading at $1.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.7M. The 52-week trading range was $1.70 to $4.96. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.